
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">ScientificWorldJournal</journal-id><journal-id journal-id-type="iso-abbrev">ScientificWorldJournal</journal-id><journal-id journal-id-type="publisher-id">TSWJ</journal-id><journal-title-group><journal-title>The Scientific World Journal</journal-title></journal-title-group><issn pub-type="ppub">2356-6140</issn><issn pub-type="epub">1537-744X</issn><publisher><publisher-name>The Scientific World Journal</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23304092</article-id><article-id pub-id-type="pmc">3523591</article-id><article-id pub-id-type="doi">10.1100/2012/925925</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Synthesis and Anti-Inflammatory Activity of New Alkyl-Substituted Phthalimide 1<italic>H</italic>-1,2,3-Triazole Derivatives</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Assis</surname><given-names>Shalom P&#x000f4;rto de Oliveira</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>da Silva</surname><given-names>Moara Targino</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Oliveira</surname><given-names>Ronaldo Nascimento</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lima</surname><given-names>Vera L&#x000fa;cia de Menezes</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Laborat&#x000f3;rio de Qu&#x000ed;mica e Metabolismo de Lip&#x000ed;deos e Lipoprote&#x000ed;nas, Departamento de Bioqu&#x000ed;mica, Universidade Federal de Pernambuco (UFPE), Avenida Prof. Moraes Rego s/n, 50670-420 Recife, PE, Brazil</aff><aff id="I2"><sup>2</sup>Laborat&#x000f3;rio de S&#x000ed;ntese de Compostos Bioativos (LSCB), Departamento de Ci&#x000ea;ncias Moleculares, Universidade Federal Rural de Pernambuco (UFRPE), Rua Dom Manoel de Medeiros s/n, Dois Irm&#x000e3;os, 52171-900 Recife, PE, Brazil</aff><author-notes><corresp id="cor1">*Vera L&#x000fa;cia de Menezes Lima: <email>lima.vera.ufpe@gmail.com</email></corresp><fn fn-type="other"><p>Academic Editors: A. Brandi, J. H. Li, A. Marra, and G. B. Shul'pin</p></fn></author-notes><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>5</day><month>12</month><year>2012</year></pub-date><volume>2012</volume><elocation-id>925925</elocation-id><history><date date-type="received"><day>2</day><month>10</month><year>2012</year></date><date date-type="accepted"><day>23</day><month>10</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2012 Shalom P&#x000f4;rto de Oliveira Assis et al.</copyright-statement><copyright-year>2012</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Four new 1,2,3-triazole phthalimide derivatives with a potent anti-inflammatory activity have been synthesized in the good yields by the 1,3-dipolar cycloaddition reaction from <italic>N</italic>-(azido-alkyl)phthalimides and terminal alkynes. The anti-inflammatory activity was determined by injecting carrageenan through the plantar tissue of the right hind paw of Swiss white mice to produce inflammation. All the compounds <bold>3a&#x02013;c</bold> and <bold>5a&#x02013;c</bold> exhibited an important anti-inflammatory activity; the best activity was found for the compounds <bold>3b</bold> and <bold>5c</bold>, which showed to be able to decrease by 69% and 56.2% carrageenan-induced edema in mice. These compounds may also offer a future promise as a new anti-inflammatory agent.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for reducing pain and swellings associated with inflammation and represent an area in continuous and evergrowing development. Phthalimide derivatives are an interesting class of compounds because they possess important biological activities [<xref rid="B1" ref-type="bibr">1</xref>], such as anti-inflammatory [<xref rid="B2" ref-type="bibr">2</xref>] and hypolipidemic [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>] ones. Glycoconjugates play an important role in many biological processes, including cellular recognition, particularly in cases of inflammation, tumor metastasis, and immune response in bacterial and viral infections [<xref rid="B5" ref-type="bibr">5</xref>].</p><p>The literature describes a series of <italic>N</italic>-phthalimidomethyl 2,3-dideoxy- and 2,3-unsaturated sugar derivatives that showed a potent anti-inflammatory activity, by exhibiting reduction of the edema induced by carrageenan [<xref rid="B2" ref-type="bibr">2</xref>]. The anti-inflammatory activity has also been recently related to 1,2,3-triazole derivatives [<xref rid="B6" ref-type="bibr">6</xref>]. The 1,2,3-triazole is a five-membered ring structure containing three nitrogen atoms and is a ring bioisosterism case of the 1,2,4-triazole. Triazoles and derivatives display a diversity of biological activities [<xref rid="B7" ref-type="bibr">7</xref>], such as anti-inflammatory [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B8" ref-type="bibr">8</xref>], hypolipidemic [<xref rid="B4" ref-type="bibr">4</xref>], antimicrobial [<xref rid="B9" ref-type="bibr">9</xref>], anticonvulsant, [<xref rid="B10" ref-type="bibr">10</xref>] and anti-nociceptive [<xref rid="B11" ref-type="bibr">11</xref>] ones. Most of these compounds and their related activity are associated with an anti-inflammatory profile [<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>].</p><p>1,2,3-Triazole represents a class of compounds that has awakened an interest in our research group by the synthesis of new heterocyclic derivatives and their biological evaluation [<xref rid="B12" ref-type="bibr">12</xref>&#x02013;<xref rid="B14" ref-type="bibr">14</xref>]. In this work the synthesis and anti-inflammatory activity of six compounds based on 1,2,3-triazoles it were performed. One group of compounds was 1,2,3-triazoles linked to unsaturated carbohydrate and phthalimides (CTP), and another one was 1,2,3-triazoles linked to phthalimides (PTP), as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. These compounds were obtained through the reaction between <italic>N</italic>-(azido-alkyl) phthalimides and terminal alkynes employing Cu-AAC (Cu-Catalyzed Azide Alkyne Cycloadditon) reaction [<xref rid="B15" ref-type="bibr">15</xref>].</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Chemistry</title><p>All reactions were monitored by TLC analysis containing GF254 and revealed in vanillin. Melting points were determined in an open capillary tube and performed on a PFM II BioSan apparatus. Elemental analyses were carried out on an EA 1110 CHNS-O analyzer from Carlo Erba Instruments. The infrared spectra were recorded on an IFS66 Bruker spectrophotometer using KBr discs. <sup>1</sup>H and <sup>13</sup>C NMR were obtained on Varian Unity Plus-300 and Varian UNMRS 400&#x02009;MHz spectrometer using CDCl<sub>3</sub> or DMSO-d<sub>6</sub> as a solvent. The polarimeter used was the Kr&#x000fc;ss, of 10&#x02009;cm path length and concentration of the solution in g/100&#x02009;mL. The purity of the compounds was attested on an HPLC-DAD Shimadzu Prominence Model.</p><sec id="sec2.1.1"><title>2.1.1. Synthesis of the Compound <bold>1</bold>
</title><p>The compound <bold>1</bold> was prepared according to a reported procedure [<xref rid="B16" ref-type="bibr">16</xref>]. The <sup>1</sup>H and <sup>13</sup>C NMR data were according to the literature [<xref rid="B17" ref-type="bibr">17</xref>]. Yield: 82%. Mp 48&#x000b0;C. [<italic>&#x003b1;</italic>]<sub><italic>D</italic><sup>25</sup></sub> + 154 (c 0.5, CH<sub>2</sub>Cl<sub>2</sub>).</p></sec><sec id="sec2.1.2"><title>2.1.2. Synthesis of the Compounds <bold>2a&#x02013;c</bold>
</title><p>The compounds <bold>2a&#x02013;c</bold> were prepared as previously reported, and the <sup>1</sup>H and <sup>13</sup>C NMR data were according to the literature [<xref rid="B12" ref-type="bibr">12</xref>].</p><p>
<statement id="head1"><title>N-2-(azidoethyl)phthalimide <bold>2a</bold>
</title><p> Yield: 75%. Solid. Mp 60-61&#x000b0;C. </p></statement>
</p><p>
<statement id="head2"><title>N-3-(azidopropyl)phthalimide <bold>2b</bold>
</title><p> Yield: 76%. Solid. Mp 40&#x000b0;C. </p></statement>
</p><p>
<statement id="head3"><title>N-4-(azidobutyl)phthalimide <bold>2c</bold>
</title><p> Yield: 70%. Solid. Mp 45&#x02013;48&#x000b0;C.</p></statement>
</p></sec><sec id="sec2.1.3"><title>2.1.3. Synthesis of the Compounds <bold>3a&#x02013;c</bold>
</title><p>The compound <bold>1</bold> (200&#x02009;mg, 0.69&#x02009;mmol) was transferred into 50&#x02009;mL flask, and it was added to 10&#x02009;mL of dichloromethane. Then, a solution containing 20&#x02009;mol% copper iodide (0.0268&#x02009;g, according to alkyne-compound), azide-phthalimides <bold>2a&#x02013;c</bold> (1.2&#x02009;equiv), and triethylamine (0.006&#x02009;g~1 drop) was added. The mixture was stirred overnight (12&#x02009;h) at r.t. (28&#x000b0;C) under argon atmosphere. A thin layer chromatography (TLC) was used to check the end of the reaction, using hexane&#x02009;:&#x02009;EtOAc (7&#x02009;:&#x02009;3) as the developing solvent system. The purification was performed by column chromatography on Merck silica gel 60 (70&#x02013;230&#x02009;mesh), using a system hexane&#x02009;:&#x02009;EtOAc (5&#x02009;:&#x02009;5). After the solvent evaporation, the product was crystallized in ethyl acetate.</p><p>
<statement id="head4"><title>4-(4,6-di-O-acetyl-2,3-dideoxy-<italic>&#x003b1;</italic>-D-erythro-hex-2-enopyranoside)-O-methyl-1-(2-phthalimidoethyl)-1,2,3-triazole (<bold>3a</bold>)</title><p>Yield: 90%. Solid. Mp 103&#x02013;106&#x000b0;C. <italic>R</italic>
<sub><italic>f</italic></sub> = 0.40 (hexane&#x02009;:&#x02009;EtOAc, 3&#x02009;:&#x02009;7). [<italic>&#x003b1;</italic>]<sub><italic>D</italic><sup>25</sup></sub> + 63.3 (c 1, CH<sub>2</sub>Cl<sub>2</sub>); IR (KBr, cm<sup>&#x02212;1</sup>): 3400, 3100, 2950, 1716, 1428, 1395, 1237, 1042, 718. <sup>1</sup>H NMR (300&#x02009;MHz, DMSO-d<sub>6</sub>): <italic>&#x003b4;</italic> 2.02 (s, 3H, CH<sub>3</sub>CO), 2.06 (s, 3H, CH<sub>3</sub>CO), 3.94&#x02013;4.03 (m, 3H, NCH<sub>2</sub> and H-5), 4.11&#x02013;4.16 (m, 2H, H-6 and H-6&#x02032;), 4.56&#x02013;4.70 (m, 4H, OCH<sub>2</sub> and NCH<sub>2</sub>Phth), 5.09 (bs, 1H, H-1), 5.20 (dd, 1H, <italic>J</italic> = 9.6 and 1.5&#x02009;Hz, H-4), 5.83&#x02013;5.85 (m, 2H, H-2 and H-3), 7.84 (m, 4H, phthalimide), 8.18 (s, 1H, H<sub>triazole</sub>). <sup>13</sup>C NMR (75.5&#x02009;MHz, CDCl<sub>3</sub>): <italic>&#x003b4;</italic> 20.8, 20.9, 37.6, 47.9, 61.2, 62.0, 65.2, 66.9, 93.4, 123.6, 127.5, 129.4, 131.6, 134.3, 167.6, 170.3, 170.8. Anal. Calc. for C<sub>23</sub>H<sub>24</sub>N<sub>4</sub>O<sub>8</sub>: C, 57.02; H, 4.99; N, 11.56. Found: C, 57.29; H, 5.36; N, 11.42.</p></statement>
</p><p>
<statement id="head5"><title>4-(4,6-di-O-acetyl-2,3-dideoxy-<italic>&#x003b1;</italic>-D-erythro-hex-2-enopyranoside)-O-methyl-1-(3-phthalimidopropyl)-1,2,3-triazole (<bold>3b</bold>)</title><p>Yield: 81%. Solid. Mp 125&#x02013;127&#x000b0;C. <italic>R</italic>
<sub><italic>f</italic></sub>&#x02009;0.40 (hexane&#x02009;:&#x02009;EtOAc, 3&#x02009;:&#x02009;7). [<italic>&#x003b1;</italic>]<sub><italic>D</italic><sup>25</sup></sub> + 49.6 (c 1, CH<sub>2</sub>Cl<sub>2</sub>); IR (KBr, cm<sup>&#x02212;1</sup>): 3468, 2925, 2854, 1770, 1710, 1491, 1399, 1231, 1037, 722. <sup>1</sup>H NMR (300&#x02009;MHz, DMSO-d<sub>6</sub>): <italic>&#x003b4;</italic> 2.03 (s, 3H, CH<sub>3</sub>CO), 2.05 (s, 3H, CH<sub>3</sub>CO), 2.18 (q, 2H, NCH<sub>2</sub>), 3.61 (t, 2H, <italic>J</italic> = 6.9&#x02009;Hz, NCH<sub>2</sub>), 3.98 (ddd, 1H, <italic>J</italic> = 9.3, 5.1 and 3.0&#x02009;Hz, H-5), 4.12&#x02013;4.15 (m, 2H, H-6 and H-6&#x02032;), 4.42 (t, 2H, <italic>J</italic> = 6.9&#x02009;Hz), 4.59 (d, 1H, <italic>J</italic> = 12&#x02009;Hz, OCHa), 4.72 (d, 1H, <italic>J</italic> = 12.3&#x02009;Hz, OCHb), 5.17 (s, 1H, H-1), 5.20 (d, 1H, <italic>J</italic> = 9.6&#x02009;Hz, H-4), 5.86 (bs, 2H, H-2 and H-3), 7.82&#x02013;7.87 (m, 4H, phthalimides), 8.12 (s, 1H, H<sub>triazole</sub>). <sup>13</sup>C NMR (75.5&#x02009;MHz, CDCl<sub>3</sub>): <italic>&#x003b4;</italic> 20.8, 20.9, 29.4, 34.9, 47.2, 60.5, 62.8, 65.2, 67.0, 93.8, 122.0, 123.4, 127.5, 128.8, 129.5, 131.7, 134.3, 143.3, 168.3, 170.3, 170.9. Anal. Calc. for C<sub>24</sub>H<sub>26</sub>N<sub>4</sub>O<sub>8</sub>: C, 57.83; H, 5.26; N, 11.24. Found: C, 57.88; H, 5.46; N, 11.14.</p></statement>
</p><p>
<statement id="head6"><title>4-(4,6-di-O-acetyl-2,3-dideoxy-<italic>&#x003b1;</italic>-D-erythro-hex-2-enopyranoside)-O-methyl-1-(4-phthalimidobutyl)-1,2,3-triazole (<bold>3c</bold>)</title><p>Yield: 68%. Solid. Mp 103&#x02013;106&#x000b0;C. <italic>R</italic>
<sub><italic>f</italic></sub> 0.40 (hexane&#x02009;:&#x02009;EtOAc, 3&#x02009;:&#x02009;7). [<italic>&#x003b1;</italic>]<sub><italic>D</italic><sup>25</sup></sub> + 37.9 (c 1, CH<sub>2</sub>Cl<sub>2</sub>); IR (KBr, cm<sup>&#x02212;1</sup>): 3464, 3141, 2935, 1769, 1711, 1437, 1398, 1370, 1230, 1038, 721. <sup>1</sup>H NMR (400&#x02009;MHz, DMSO-d<sub>6</sub>): <italic>&#x003b4;</italic> 1.54&#x02013;1.60 (q, 2H, CH<sub>2</sub>), 1.82&#x02013;1.85 (q, 2H, CH<sub>2</sub>), 2.03 (s, 3H, CH<sub>3</sub>CO), 2.05 (s, 3H, CH<sub>3</sub>CO), 3.60 (t, 2H, <italic>J</italic> = 6.8&#x02009;Hz, NCH<sub>2</sub>), 3.98 (ddd, 1H, <italic>J</italic> = 8.8, 5.2 and 3.2&#x02009;Hz, H-5), 4.09&#x02013;4.17 (m, 2H, H-6 and H-6&#x02032;), 4.37 (t, 2H, <italic>J</italic> = 6.8&#x02009;Hz), 4.60 (d, 1H, <italic>J</italic> = 12.4&#x02009;Hz, OCH<sub>a</sub>), 4.72 (d, 1H, <italic>J</italic> = 12.4&#x02009;Hz, OCH<sub>b</sub>), 5.17 (s, 1H, H-1), 5.20 (d, 1H, <italic>J</italic> = 9.6&#x02009;Hz, H-4), 5.86 (bs, 2H, H-2 and H-3), 7.82&#x02013;7.87 (m, 4H, phthalimides), 8.10 (s, 1H, H<sub>triazole</sub>). <sup>13</sup>C NMR (75.5&#x02009;MHz, CDCl<sub>3</sub>): <italic>&#x003b4;</italic> 20.8, 20.9, 25.5, 27.4, 29.6, 36.7, 49.4, 61.4, 62.7, 65.1, 66.9, 93.7, 122.7, 123.2, 127.4, 129.4, 131.8, 134.0, 144.0, 168.3, 170.2, 170.8. Anal. Calc. for C<sub>25</sub>H<sub>28</sub>N<sub>4</sub>O<sub>8</sub>: C, 58.59; H, 5.51; N, 10.93. Found: C, 58.47; H, 5.30; N, 10.56.</p></statement>
</p></sec><sec id="sec2.1.4"><title>2.1.4. Synthesis of the Compounds <bold>5a&#x02013;c</bold>
</title><p>The N-(azido-alkyl)phthalimide <bold>2a&#x02013;c</bold> was transferred into 50&#x02009;mL flask and it was added to 10&#x02009;mL of dichloromethane. Then, a solution of 20&#x02009;mol% copper iodide (according to alkyne-compound), 1.5 equiv. N-propargyl phthalimide <bold>4</bold>, and triethylamine (20&#x02009;mol%) was added. The mixture was stirred for 12&#x02009;h at room temperature (28&#x000b0;C) under argon atmosphere. The purification was performed by column chromatography on Merck silica gel 60 (70&#x02013;230&#x02009;mesh). After the solvent evaporation, the product was crystallized in dichloromethane-hexane.</p><p>
<statement id="head7"><title>4-(N-Phthalimidomethyl)-1-(2-phthalimidoethyl)-1,2,3-triazole (<bold>5a</bold>)</title><p>Yield: 77%. Solid. Mp 226&#x02013;230&#x000b0;C. <italic>R</italic>
<sub><italic>f</italic></sub> 0.14 (hexane&#x02009;:&#x02009;EtOAc, 1&#x02009;:&#x02009;1). IR (KBr, cm<sup>&#x02212;1</sup>): 3582, 3459, 3144, 3094, 2951, 1771, 1703, 1466, 1428, 1398, 1322, 1224, 1101, 936, 718, 531. <sup>1</sup>H NMR (400&#x02009;MHz, CDCl<sub>3</sub>): <italic>&#x003b4;</italic> 4.13 (t, 2H, <italic>J</italic> = 6.4&#x02009;Hz, NCH<sub>2</sub>), 4.64 (t, 2H, <italic>J</italic> = 6.0&#x02009;Hz, NCH<sub>2</sub>), 4.97 (s, 2H, CH<sub>2</sub>), 7.68&#x02013;7.73 (m, 5H, phthalimide and H<sub>triazole</sub>), 7.78 (m, 2H, phthalimide), 7.85 (m, 2H, phthalimide). <sup>13</sup>C NMR (100&#x02009;MHz, CDCl<sub>3</sub>): <italic>&#x003b4;</italic> 33.0, 37.6, 47.9, 123.4, 123.6, 131.7, 132.1, 134.0, 134.2, 167.6. Anal. Calc. for C<sub>21</sub>H<sub>15</sub>N5O<sub>4</sub> (0.9&#x000b7;H<sub>2</sub>O): C, 60.40; H, 4.05; N, 16.77. Found: C, 60.70; H, 4.35; N, 16.49. </p></statement>
</p><p>
<statement id="head8"><title>4-(N-Phthalimidomethyl)-1-(3-phthalimidopropyl)-1,2,3-triazole (<bold>5b</bold>)</title><p>Yield: 62%. Solid. Mp 150&#x02013;152&#x000b0;C; <italic>R</italic>
<sub><italic>f</italic></sub> 0.44 (CH<sub>2</sub>Cl<sub>2</sub>&#x02009;:&#x02009;EtOAc, 9&#x02009;:&#x02009;1). The NMR <sup>1</sup>H and <sup>13</sup>C data is in accordance with the literature [<xref rid="B12" ref-type="bibr">12</xref>]. </p></statement>
</p><p>
<statement id="head9"><title>4-(N-Phthalimidomethyl)-1-(4-phthalimidobutyl)-1,2,3-triazole (<bold>5c</bold>)</title><p>The purification started with 20% EtOAc in hexane to 100% ethyl acetate. The product was crystallized in dichloromethane and hexane. Yield: 88%. Solid. Mp 151&#x02013;153&#x000b0;C; Lit. 150&#x02013;151&#x000b0;C. <italic>R</italic>
<sub><italic>f</italic></sub> 0.34 (CH<sub>2</sub>Cl<sub>2</sub>&#x02009;:&#x02009;EtOAc, 9&#x02009;:&#x02009;1). The spectroscopic data is in agreement with the reported data [<xref rid="B12" ref-type="bibr">12</xref>]. </p></statement>
</p></sec></sec><sec id="sec2.2"><title>2.2. Pharmacology</title><sec id="sec2.2.1"><title>2.2.1. Animals</title><p>Three-month-old Swiss white mice, 25&#x02013;30&#x02009;g body weight, were maintained with water and food (Labina, Agribands Brazil Ltd.) <italic>ad libitum</italic>. Groups of 10 animals were separate for each experiment. All experiments reported here are in accordance with the Animal Care and Use Committee at the Federal University of Pernambuco and guidelines for Care and Use of Laboratory Animals (of. number 098/2002).</p></sec><sec id="sec2.2.2"><title>2.2.2. Acute Anti-Inflammatory Activity</title><p>The drugs used for comparison purposes were <bold>3a&#x02013;c</bold>, <bold>5a&#x02013;c</bold>, ibuprofen, and ASA. All compounds were suspended in 1% carboxymethylcellulose (CMC) and single dose of 250&#x02009;mg/Kg was administered intraperitoneally, in the morning [<xref rid="B18" ref-type="bibr">18</xref>]. Other animal group received 1% CMC. Two positive and one negative anti-inflammatory control tests were done in three animal groups by intraperitoneal administration of 250&#x02009;mg/Kg of acetylsalicylic acid (ASA), a standard dose for pharmacological comparative tests, 250&#x02009;mg/Kg of ibuprofen (Laboratory Teuto Brazilian Ltd., Brazil), and 0.9% of aqueous saline solution, respectively. The anti-inflammatory activity was determined by Levy's method [<xref rid="B19" ref-type="bibr">19</xref>]. Carrageenan (Sigma, St. Louis, USA), 0.1&#x02009;mL of a 1% solution in 0.9% NaCl, was injected through the plantar tissue of the right hind paw of each mouse to produce inflammation. After four hours, the animals were sacrificed under anesthesia and their paws were cut and weighed. The results were analyzed according to the percentage of inflammation reduction as described earlier [<xref rid="B19" ref-type="bibr">19</xref>].</p></sec><sec id="sec2.2.3"><title>2.2.3. Effective Dose for Anti-Inflammatory Activity</title><p>Compounds <bold>3b</bold> and <bold>5c</bold>, ASA, and ibuprofen (obtained from Bristol-Myers Squibb, Brazil) were dissolved individually in 1% CMC and administrated as described above at doses of 50, 100, 150, 200, 250, and 350&#x02009;mg/Kg.</p></sec><sec id="sec2.2.4"><title>2.2.4. Calculation of Octanol-Water Partition Coefficient &#x02212;log&#x02061;<italic>P</italic>&#x02009;[<xref rid="B20" ref-type="bibr">20</xref>]</title><p>The structures of compounds <bold>3a&#x02013;c</bold> and <bold>5a&#x02013;c </bold>were analyzed in ACD/Labs that contains a database available for this procedure. The values of octanol-water partition coefficient (log&#x02061;<italic>P</italic>) for these compounds were predicted using Advanced Chemistry Development Inc. (ACD/Labs, algorithm version: v5.0.0.184). </p></sec><sec id="sec2.2.5"><title>2.2.5. Statistics</title><p>All results are expressed as mean &#x000b1; SEM for experiments. Statistical evaluation was undertaken by analysis of variance (ANOVA) followed by Turkey test for multiple comparisons. <italic>P</italic> &#x0003c; 0.05 was used as the criterion of statistical significance.</p></sec></sec></sec><sec id="sec3"><title>3. Results and Discussion</title><sec id="sec3.1"><title>3.1. Chemistry</title><p>The synthetic strategy to obtain the compounds <bold>3a&#x02013;c</bold> consists of two convergent steps. First, the alkyne carbohydrate <bold>1</bold> was prepared in 82% of yield according to Ferrier's protocol [<xref rid="B16" ref-type="bibr">16</xref>]. In parallel, the synthesis of <italic>N</italic>-(azido-alkyl)phthalimides <bold>2a&#x02013;c</bold> was achieved from the corresponding <italic>N</italic>-(bromoalkyl)phthalimide in good yields (70%&#x02013;75%). Finally, the glycoconjugate 1,2,3-triazoles <bold>3a&#x02013;c</bold> were initially prepared using the protocol described in a previous work [<xref rid="B12" ref-type="bibr">12</xref>] to afford the compound <bold>3a</bold> in moderate yield (48%). Thus, when 1 drop of triethylamine was added the desired compounds were obtained in good yield (90%). Under this optimized conditions the compounds <bold>3a&#x02013;c</bold> were synthesized in good yields of 68%&#x02013;90% after column chromatography on silica gel (<xref ref-type="fig" rid="sch1">Scheme 1</xref>). </p><p>The <italic>N</italic>-propargyl phthalimide <bold>4</bold> was prepared from potassium phthalimide and propargyl bromide after being stirred at room temperature for 24&#x02009;h. The reaction between alkyne <bold>4</bold> and <italic>N</italic>-(azido-alkyl)-phthalimides <bold>2a&#x02013;c</bold> was carried out at the same conditions described above. This facile protocol provided the bis-phthalimides 1,2,3-triazole <bold>5a&#x02013;c</bold> in good yields of 62%&#x02013;88%, as shown in <xref ref-type="fig" rid="sch2">Scheme 2</xref>.</p></sec><sec id="sec3.2"><title>3.2. Pharmacology</title><p>All the compounds exhibited anti-inflammatory activity when compared with ASA as well as ibuprofen. The compounds <bold>3a</bold>, <bold>3b</bold>, and <bold>3c</bold> reduced carrageenan-induced edema in Swiss white mice by 33.7%, 69%, and 44%, respectively. This result is significant (<italic>P</italic> &#x0003c; 0.001) when compared with the control group treated with the saline solution (<xref ref-type="table" rid="tab1">Table 1</xref>). </p><p>The compounds <bold>5a</bold>,<bold> 5b</bold>, and<bold> 5c</bold> were able to reduce the edema by 17%, 25%, and 56.2%, respectively, as shown in <xref ref-type="table" rid="tab1">Table 1</xref>. Therefore, substances <bold>3b</bold> and <bold>5c </bold>showed the best anti-inflammatory activity in terms of edema inhibition. </p><p>The <bold>3b</bold> and <bold>5c </bold>compounds, which showed the greatest anti-inflammatory effect, were selected for the experiment of determining the effective dose. The study of effective dose has shown that closely at concentration of 225&#x02009;mg/Kg the compounds <bold>3b</bold> and <bold>5c</bold> have 50% of anti-inflammatory activity (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The results of anti-inflammatory dose-response curves for the compounds <bold>3b</bold> and <bold>5c</bold> showed similar results to the ASA at all concentrations tested. On the other hand, the anti-inflammatory effect of compounds <bold>3b</bold> and <bold>5c</bold> was similar to ibuprofen only when administered at high dose (350&#x02009;mg/Kg), as shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>. </p><p>According to <xref ref-type="table" rid="tab1">Table 1</xref> the acute anti-inflammatory activity of considering the compounds <bold>3a&#x02013;c</bold> containing phthalimide linked to carbohydrate (CTP) the best anti-inflammatory activity was observed for the compound <bold>3b</bold> that contains three methylene groups. However, for compounds <bold>5a&#x02013;c</bold> that have two moieties of phthalimide connected to a triazole ring (PTP), when increasing the size of aliphatic chain, the anti-inflammatory activity is also increased from 17% (<italic>n</italic> = 2) to 56.2% (<italic>n</italic> = 4) (<xref ref-type="table" rid="tab1">Table 1</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>). </p><p>Hydrophobic interactions play a key role in the folding and maintenance of the three-dimensional structure of proteins, as well as in the binding of ligands (e.g., drugs) to protein targets [<xref rid="B21" ref-type="bibr">21</xref>]. Protein-ligand binding is partially driven by lipophilic interaction, and the log&#x02061;<italic>P</italic> for a class of ligand compounds will depend on the nature of protein. In fact, it is known in the literature that chain branching or homologation can cause the molecule to bind more or less well to the receptors responsible for specific biological activity [<xref rid="B22" ref-type="bibr">22</xref>]. </p><p>In order to evaluate the chain effect on the anti-inflammatory activity we have calculated the partition coefficient (log&#x02061;<italic>P</italic>) using the ADC/Labs PhysChem Predictor. The log&#x02061;<italic>P</italic> values are important data to be considered for drug design and their pharmacokinetics properties; they indicate the lipophilic tendency or the ability to penetrate lipid barriers (lipophilicity) [<xref rid="B23" ref-type="bibr">23</xref>]. </p><p>The chain effect for the biological activity in both classes of the compounds <bold>3</bold> and <bold>5 </bold>is shown in <xref ref-type="table" rid="tab2">Table 2</xref>, and the log&#x02061;<italic>P</italic> ranged from 1.53 to 2.04 and from 2.37 to 2.89, respectively. </p><p>The compounds <bold>3a&#x02013;c</bold> have a portion carbohydrate, and for this class we can note that a peak anti-inflammatory activity occurred with the 3-phthalimide propyl-1,2,3-triazole <bold>3b </bold>(<xref ref-type="fig" rid="fig3">Figure 3</xref>). On the other hand, the class of compounds <bold>5a&#x02013;c</bold> is more lipophilic and showed to be sensitive to anti-inflammatory activity when the methylene groups were introduced. </p><p>In recent works, a new series of 1-[2-(1<italic>H</italic>-tetrazol-5-yl)ethyl]-1<italic>H</italic>-benzo[d][1,2, 3]triazoles have shown anti-inflammatory activity (11&#x02013;47%) against carrageenan-induced paw edema, whereas the standard drug diclofenac sodium showed 61% [<xref rid="B24" ref-type="bibr">24</xref>]. Other novel series of azoles, such as pyrazole, were obtained by reacting chalcones and hydrazine hydrate, and they exhibited low inhibition of paw edema ranging 1.08&#x02013;31.05%, and these results corresponded to a percentage of the indomethacin inhibition [<xref rid="B25" ref-type="bibr">25</xref>]. However, in the present work, the compounds <bold>3b</bold> and <bold>5c</bold> exhibited better anti-inflammatory activity (<xref ref-type="fig" rid="fig2">Figure 2</xref>) than that reported by Khalil [<xref rid="B25" ref-type="bibr">25</xref>], when considering the anti-inflammatory effect of <bold>3b</bold> and <bold>5c</bold> observed with 50&#x02009;mg/Kg (lower dose) in relation to the same concentration of ibuprofen or ASA instead of that of the saline.</p><p>Recently, a series of new 1,2,4-triazoles obtained by reacting acyl 1,2,4-triazoles with various secondary amines, exhibited appreciable inhibition [<xref rid="B8" ref-type="bibr">8</xref>]; when, administered at a dose of 100&#x02009;mg/Kg, the percentage inhibition reached 55.6%, the comparison was performed with the reference drug indomethacin (62.5% at 100&#x02009;mg/Kg). These results are similar to the compounds <bold>3b</bold> and <bold>5c</bold>, which were administered by us at a dose of 250&#x02009;mg/Kg.</p><p>There are scientific evidences that the <italic>bis</italic>-heterocyclic compounds encompassing 2-mercapto benzothiazole and 1,2,3-triazole showed significant binding potential towards COX enzyme thus lowering the paw edema induced by carrageenan [<xref rid="B6" ref-type="bibr">6</xref>]. The class of monoacylated 5-amino-1,2,4-triazole derivatives exhibited potent anti-inflammatory activity (at 5&#x02009;mg/kg, oral dose level) in carrageenan-induced rat paw edema test [<xref rid="B26" ref-type="bibr">26</xref>]. These results also contributed to show that many structure containing the heterocyclic triazole possessed high anti-inflammatory activity.</p><p>New 1H-(1,2,3-triazole)phthalimide derivatives are interesting drugs due to their potential anti-inflammatory activity, thus deserving further studies in order to understand the mechanism of action. In conclusion, the results suggest that these compounds may also offer a future promise as a new anti-inflammatory agent.</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors are grateful to Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Ci&#x000ea;ncia e Tecnologia do Estado de Pernambuco (FACEPE), Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (CAPES), Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq), and Brazilian agencies for financial support. They authors are indebted to the Analytical Centers DQF-UFPE and CENAPESQ-UFRPE. </p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves Filho</surname><given-names>RAW</given-names></name><name><surname>Palm-Forster</surname><given-names>MAT</given-names></name><name><surname>De Oliveira</surname><given-names>RN</given-names></name></person-group><article-title>Imidazole-promoted Synthesis of N-substituted phthalimides from N,N&#x02019;-disubstituted ureas in solventless conditions</article-title><comment><italic>Synthesis Communication</italic>. In press. Online first at <ext-link ext-link-type="uri" xlink:href="http://www.tandfonline.com/doi/abs/10.1080/00397911.2011.651677">http://www.tandfonline.com/doi/abs/10.1080/00397911.2011.651677</ext-link></comment></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>XB</given-names></name><name><surname>Han</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>SN</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Cui</surname><given-names>JR</given-names></name><name><surname>Li</surname><given-names>ZJ</given-names></name></person-group><article-title>Synthesis and anti-inflammatory activity of N-phthalimidomethyl 2,3-dideoxy- and 2,3-unsaturated glycosides</article-title><source><italic>Carbohydrate Research</italic></source><year>2007</year><volume>342</volume><issue>9</issue><fpage>1169</fpage><lpage>1174</lpage><pub-id pub-id-type="other">2-s2.0-34247500862</pub-id><pub-id pub-id-type="pmid">17407773</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>IH</given-names></name><name><surname>Voorstad</surname><given-names>PJ</given-names></name><name><surname>Chapman</surname><given-names>JM</given-names></name><name><surname>Cocolas</surname><given-names>GH</given-names></name></person-group><article-title>Antihyperlipidemic activity of phthalimide analogues in rodents</article-title><source><italic>Journal of Pharmaceutical Sciences</italic></source><year>1983</year><volume>72</volume><issue>8</issue><fpage>845</fpage><lpage>851</lpage><pub-id pub-id-type="other">2-s2.0-0020572597</pub-id><pub-id pub-id-type="pmid">6620134</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sena</surname><given-names>VLM</given-names></name><name><surname>Srivastava</surname><given-names>RM</given-names></name><name><surname>Silva</surname><given-names>RO</given-names></name><name><surname>Lima</surname><given-names>VLM</given-names></name></person-group><article-title>Synthesis and hypolipidemic activity of N-substituted phthalimides. Part V</article-title><source><italic>Farmaco</italic></source><year>2003</year><volume>58</volume><issue>12</issue><fpage>1283</fpage><lpage>1288</lpage><pub-id pub-id-type="other">2-s2.0-0242636463</pub-id><pub-id pub-id-type="pmid">14630240</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000f6;lemann</surname><given-names>A</given-names></name><name><surname>Seeberger</surname><given-names>PH</given-names></name></person-group><article-title>Carbohydrate diversity: synthesis of glycoconjugates and complex carbohydrates</article-title><source><italic>Current Opinion in Biotechnology</italic></source><year>2004</year><volume>15</volume><issue>6</issue><fpage>615</fpage><lpage>622</lpage><pub-id pub-id-type="other">2-s2.0-9244224089</pub-id><pub-id pub-id-type="pmid">15560990</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafi</surname><given-names>S</given-names></name><name><surname>Alam</surname><given-names>MM</given-names></name><name><surname>Mulakayala</surname><given-names>N</given-names></name><etal/></person-group><article-title>Synthesis of novel 2-mercapto benzothiazole and 1, 2, 3-triazole based <italic>bis</italic>-heterocycles: their anti-inflammatory and anti-noceptive activites</article-title><source><italic>European Journal Medicinal Chemistry</italic></source><year>2012</year><volume>49</volume><issue>31</issue><fpage>324</fpage><lpage>333</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agalave</surname><given-names>SG</given-names></name><name><surname>Maujan</surname><given-names>SR</given-names></name><name><surname>Pore</surname><given-names>VS</given-names></name></person-group><article-title>Click chemistry: 1, 2, 3-triazole as pharmacophores</article-title><source><italic>Chemistry Asian Journal</italic></source><year>2011</year><volume>6</volume><issue>10</issue><fpage>2696</fpage><lpage>2718</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upmanyu</surname><given-names>N</given-names></name><name><surname>Gupta</surname><given-names>JK</given-names></name><name><surname>Shah</surname><given-names>K</given-names></name><name><surname>Mishra</surname><given-names>P</given-names></name></person-group><article-title>Synthesis of new 1,2,4-triazoles as anti-inflammatory and anti-nociceptive agents</article-title><source><italic>Pharmaceutical Chemistry Journal</italic></source><year>2011</year><volume>45</volume><issue>7</issue><fpage>433</fpage><lpage>439</lpage></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karegoudar</surname><given-names>P</given-names></name><name><surname>Prasad</surname><given-names>DJ</given-names></name><name><surname>Ashok</surname><given-names>M</given-names></name><name><surname>Mahalinga</surname><given-names>M</given-names></name><name><surname>Poojary</surname><given-names>B</given-names></name><name><surname>Holla</surname><given-names>BS</given-names></name></person-group><article-title>Synthesis, antimicrobial and anti-inflammatory activities of some 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles and 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines bearing trichlorophenyl moiety</article-title><source><italic>European Journal of Medicinal Chemistry</italic></source><year>2008</year><volume>43</volume><issue>4</issue><fpage>808</fpage><lpage>815</lpage><pub-id pub-id-type="other">2-s2.0-41449111442</pub-id><pub-id pub-id-type="pmid">17804121</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>LP</given-names></name><name><surname>Jin</surname><given-names>QH</given-names></name><name><surname>Tian</surname><given-names>GR</given-names></name><name><surname>Chai</surname><given-names>KY</given-names></name><name><surname>Quan</surname><given-names>ZS</given-names></name></person-group><article-title>Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [4, 3 -a] quinoline derivatives as potent anticonvulsants</article-title><source><italic>Journal of Pharmacy &#x00026; Pharmaceutical Sciences</italic></source><year>2007</year><volume>10</volume><issue>3</issue><fpage>254</fpage><lpage>262</lpage><pub-id pub-id-type="other">2-s2.0-34447508262</pub-id><pub-id pub-id-type="pmid">17727789</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajasekaran</surname><given-names>A</given-names></name><name><surname>Rajagopal</surname><given-names>KA</given-names></name></person-group><article-title>Synthesis of some novel triazole derivatives as anti-nociceptive and anti-inflammatory agents</article-title><source><italic>Acta Pharmaceutica</italic></source><year>2009</year><volume>59</volume><issue>3</issue><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="other">2-s2.0-70350110874</pub-id><pub-id pub-id-type="pmid">19819831</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>FCG</given-names></name><name><surname>De Oliveira</surname><given-names>RN</given-names></name></person-group><article-title>Synthesis of a new class of triazole-linked benzoheterocycles via 1,3-dipolar cycloaddition</article-title><source><italic>Journal of the Brazilian Chemical Society</italic></source><year>2011</year><volume>22</volume><issue>3</issue><fpage>592</fpage><lpage>597</lpage><pub-id pub-id-type="other">2-s2.0-79951966702</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nascimento</surname><given-names>WS</given-names></name><name><surname>Camara</surname><given-names>CA</given-names></name><name><surname>De Oliveira</surname><given-names>RN</given-names></name></person-group><article-title>Synt<italic>h</italic>esis of 2-(1<italic>H</italic>-1, 2, 3-triazole-1-yl)-1, 4-naphthoquinones from 2-azide-1, 4-naphthoquinone and terminal alkynes</article-title><source><italic>Synthesis</italic></source><year>2011</year><volume>20</volume><issue>20</issue><fpage>3220</fpage><lpage>3224</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Silva</surname><given-names>EN</given-names><suffix>Jr.</suffix></name><name><surname>De Melo</surname><given-names>IMM</given-names></name><name><surname>Diogo</surname><given-names>EBT</given-names></name><etal/></person-group><article-title>On the search for potential anti-trypanosoma cruzi drugs: synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1, 2, 3-triazolic naphthoquinoidal compounds obtained by click chemistry reaction</article-title><source><italic>European Journal Medicinal Chemistry</italic></source><year>2012</year><volume>52</volume><fpage>304</fpage><lpage>312</lpage></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rostovtsev</surname><given-names>VV</given-names></name><name><surname>Green</surname><given-names>LG</given-names></name><name><surname>Fokin</surname><given-names>VV</given-names></name><name><surname>Sharpless</surname><given-names>KB</given-names></name></person-group><article-title>A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective &#x02018;Ligation&#x02019; of azides and terminal alkines</article-title><source><italic>Angewandte Chemie International Edition</italic></source><year>2002</year><volume>41</volume><fpage>2596</fpage><lpage>2599</lpage><pub-id pub-id-type="pmid">12203546</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toshima</surname><given-names>K</given-names></name><name><surname>Ishizuka</surname><given-names>T</given-names></name><name><surname>Malsuo</surname><given-names>G</given-names></name><name><surname>Nakata</surname><given-names>M</given-names></name></person-group><article-title>Practical glycosidation method of glycals using montmorillonite K-10 as an environmentally acceptable and inexpensive industrial catalyst</article-title><source><italic>Synlett</italic></source><year>1995</year><volume>4</volume><issue>11</issue><fpage>306</fpage><lpage>308</lpage></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De</surname><given-names>K</given-names></name><name><surname>Legros</surname><given-names>J</given-names></name><name><surname>Crousse</surname><given-names>B</given-names></name><name><surname>Bonnet-Delpon</surname><given-names>D</given-names></name></person-group><article-title>Synthesis of 2,3-unsaturated glycosides via metal-free Ferrier reaction</article-title><source><italic>Tetrahedron</italic></source><year>2008</year><volume>64</volume><issue>46</issue><fpage>10497</fpage><lpage>10500</lpage><pub-id pub-id-type="other">2-s2.0-52949145602</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falc&#x000e3;o</surname><given-names>EPDS</given-names></name><name><surname>De Melo</surname><given-names>SJ</given-names></name><name><surname>Srivastava</surname><given-names>RM</given-names></name><name><surname>Catanho</surname><given-names>MTJDA</given-names></name><name><surname>Do Nascimento</surname><given-names>SC</given-names></name></person-group><article-title>Synthesis and antiinflammatory activity of 4-amino-2-aryl-5-cyano-6-{3- and 4-(N-phthalimidophenyl)} pyrimidines</article-title><source><italic>European Journal of Medicinal Chemistry</italic></source><year>2006</year><volume>41</volume><issue>2</issue><fpage>276</fpage><lpage>282</lpage><pub-id pub-id-type="other">2-s2.0-33644933323</pub-id><pub-id pub-id-type="pmid">16414151</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>L</given-names></name></person-group><article-title>Carrageenan paw edema in the mouse</article-title><source><italic>Life Sciences</italic></source><year>1969</year><volume>8</volume><issue>11</issue><fpage>601</fpage><lpage>606</lpage><pub-id pub-id-type="other">2-s2.0-0014529294</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrauskas</surname><given-names>AA</given-names></name><name><surname>Kolovanov</surname><given-names>EA</given-names></name></person-group><article-title>ACD/Log <italic>P</italic> method description</article-title><source><italic>Perspectives in Drug Discovery and Design</italic></source><year>2000</year><volume>19</volume><issue>1</issue><fpage>99</fpage><lpage>116</lpage><pub-id pub-id-type="other">2-s2.0-0033820398</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efremov</surname><given-names>RG</given-names></name><name><surname>Chugunov</surname><given-names>AO</given-names></name><name><surname>Pyrkov</surname><given-names>TV</given-names></name><name><surname>Priestle</surname><given-names>JP</given-names></name><name><surname>Arseniev</surname><given-names>AS</given-names></name><name><surname>Jacoby</surname><given-names>E</given-names></name></person-group><article-title>Molecular lipophilicity in protein modeling and drug design</article-title><source><italic>Current Medicinal Chemistry</italic></source><year>2007</year><volume>14</volume><issue>4</issue><fpage>393</fpage><lpage>415</lpage><pub-id pub-id-type="other">2-s2.0-33847217585</pub-id><pub-id pub-id-type="pmid">17305542</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>RB</given-names></name></person-group><source><italic>The Organic Chemistry of Drug Design and Drug Action</italic></source><year>2004</year><publisher-loc>Burlington, Mass, USA</publisher-loc><publisher-name>Elsevier/Academic Press</publisher-name></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nogrady</surname><given-names>T</given-names></name><name><surname>Weaver</surname><given-names>DF</given-names></name></person-group><source><italic>Medicinal Chemistry: A Molecular and Biochemical Approach</italic></source><year>2005</year><edition>3rd edition</edition><publisher-loc>New York, NY, USA</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajasekaran</surname><given-names>A</given-names></name><name><surname>Rajagopal</surname><given-names>KA</given-names></name></person-group><article-title>Synthesis of some novel triazole derivatives as anti-nociceptive and anti-inflammatory agents</article-title><source><italic>Acta Pharmaceutica</italic></source><year>2009</year><volume>59</volume><issue>3</issue><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="other">2-s2.0-70350110874</pub-id><pub-id pub-id-type="pmid">19819831</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalil</surname><given-names>OM</given-names></name></person-group><article-title>Synthesis and anti-inflammatory of 1-acetyl/propanoyl-5-aryl-3-(4-morpholinophenyl)-4, 5-dihydro-1<italic>H</italic>-pyrazole derivatives</article-title><source><italic>Medicinal Chemistry Research</italic></source><year>2012</year><volume>21</volume><issue>10</issue><fpage>3240</fpage><lpage>3245</lpage></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Megeed</surname><given-names>AM</given-names></name><name><surname>Abdel-Rahman</surname><given-names>HM</given-names></name><name><surname>Alkaramany</surname><given-names>GES</given-names></name><name><surname>El-Gendy</surname><given-names>MA</given-names></name></person-group><article-title>Design, synthesis and molecular modeling study of acylated 1,2,4-triazole-3-acetates with potential anti-inflammatory activity</article-title><source><italic>European Journal of Medicinal Chemistry</italic></source><year>2009</year><volume>44</volume><issue>1</issue><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="other">2-s2.0-57949107840</pub-id><pub-id pub-id-type="pmid">18455273</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Molecules based on Carbohydrate-Triazole-Phthalimides (CTP) and Phthalimide-Triazole-Phthalimides (PTP).</p></caption><graphic xlink:href="TSWJ2012-925925.001"/></fig><fig id="sch1" orientation="portrait" position="float"><label>Scheme 1</label><caption><p>Synthesis of compounds <bold>3a&#x02013;c</bold>.</p></caption><graphic xlink:href="TSWJ2012-925925.sch.001"/></fig><fig id="sch2" orientation="portrait" position="float"><label>Scheme 2</label><caption><p>Synthesis of compounds<bold> 5a&#x02013;c</bold>.</p></caption><graphic xlink:href="TSWJ2012-925925.sch.002"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Anti-inflammatory dose-response curves for compounds <bold>3b</bold>, <bold>5c</bold>, ASA, and ibuprofen using carrageenan to produce inflammation in the paw of mice.</p></caption><graphic xlink:href="TSWJ2012-925925.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Analysis of anti-inflammatory activity (%) versus variation of size aliphatic chain in the compounds <bold>3a&#x02013;c </bold>(CTP) and <bold>5a&#x02013;c </bold>(PTP).</p></caption><graphic xlink:href="TSWJ2012-925925.003"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Acute anti-inflammatory activity of 1,2,3-triazole phthalimides <bold>3a&#x02013;c</bold> and <bold>5a&#x02013;c</bold> after carrageenin-induced edema at dose 250&#x02009;mg&#x000b7;kg<sup>&#x02212;1</sup>. </p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Compounds</th><th align="center" rowspan="1" colspan="1">Difference in paw weight (<bold>g</bold>) &#x000b1; SEM</th><th align="center" rowspan="1" colspan="1">Edema inhibition (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>3a</bold>
</td><td align="center" rowspan="1" colspan="1">0.1030 &#x000b1; 0.0129**</td><td align="center" rowspan="1" colspan="1">33.7</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>3b</bold>
</td><td align="center" rowspan="1" colspan="1">0.0485 &#x000b1; 0.0160**</td><td align="center" rowspan="1" colspan="1">69.0</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>3c</bold>
</td><td align="center" rowspan="1" colspan="1">0.0865 &#x000b1; 0.0385**</td><td align="center" rowspan="1" colspan="1">44.0</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>5a</bold>
</td><td align="center" rowspan="1" colspan="1">0.1247 &#x000b1; 0.0119**</td><td align="center" rowspan="1" colspan="1">17.0</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>5b</bold>
</td><td align="center" rowspan="1" colspan="1">0.1166 &#x000b1; 0.0308*</td><td align="center" rowspan="1" colspan="1">25.0</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>5c</bold>
</td><td align="center" rowspan="1" colspan="1">0.0680 &#x000b1; 0.0128**</td><td align="center" rowspan="1" colspan="1">56.2</td></tr><tr><td align="left" rowspan="1" colspan="1">1% Carboxymethylcellulose</td><td align="center" rowspan="1" colspan="1">0.1461 &#x000b1; 0.0168<sup>ns</sup>
</td><td align="center" rowspan="1" colspan="1">6.0</td></tr><tr><td align="left" rowspan="1" colspan="1">0.9% saline solution </td><td align="center" rowspan="1" colspan="1">0.1553 &#x000b1; 0.0172<sup>ns</sup>
</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">0.0421 &#x000b1; 0.0134**</td><td align="center" rowspan="1" colspan="1">73.0</td></tr><tr><td align="left" rowspan="1" colspan="1">ASA</td><td align="center" rowspan="1" colspan="1">0.0502 &#x000b1; 0.0237**</td><td align="center" rowspan="1" colspan="1">68.0</td></tr></tbody></table><table-wrap-foot><fn><p>Significant differences: *<italic>P</italic> &#x0003c; 0.05; **<italic>P</italic> &#x0003c; 0.001; ns: not significant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Structure activity and log&#x02061;<italic>P</italic> values calculated. </p></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1">
<graphic xlink:href="TSWJ2012-925925.tab.001"/>
</td></tr></tbody></table><table-wrap-foot><fn><p>*log&#x02061;<italic>P</italic> values were calculated using Advanced Chemistry Development (ACD/Labs Algorithm Version: v5.0.0.184).</p></fn></table-wrap-foot></table-wrap></floats-group></article>